Ultragenyx Pharmaceutical Inc. Reports annual revenue of $434.2 million
Company Records $606.6 million loss
By USInMinutes
Published - Mar 05, 2024, 09:09 AM ET
Last Updated - Mar 05, 2024, 09:09 AM EST
Ultragenyx Pharmaceutical Inc. [RARE] has reported $434.2 million in revenue for year ended Dec 31, 2023.
Also Read:
